GUTS logo

FRACTYL HEALTH INC

GUTSNASDAQ
๐Ÿ† #4742 by market capUS Equity
$0.83โ–ผ $0.13 (โˆ’13.50%)
Market closed ยท at close
๐Ÿ””
Track GUTS
Get earnings, price moves & breaking news on Telegram
Track
24hโ–ผ 13.5%
7dโ–ผ 7.6%
14dโ–ผ 9.9%
30dโ–ผ 23.7%
ytdโ–ผ 96.9%
1yโ–ผ 95.0%
๐ŸฆMarket Cap
$11M
Small Cap
๐Ÿ“ˆRevenue Growth (YoY)
โ€”
๐Ÿ“ŠGross Margin
46.2%
Healthy
๐Ÿ’ตFCF Margin
โ€”
โš–๏ธP/S Ratio
117.0x
Expensive
Otter Score
โ€”
Insufficient data

Trading Snapshot

Day Range
$0.79 โ€“ $0.95
52-Week Range
$0.78 โ€“ $29.34
Volume (shares)
5,788
Avg Volume (shares)
โ€”
Shares Outstanding
13.3M
Next Earnings
โ€”

Fundamentals Snapshot

Annual Revenue
โ€”
Last Q Revenue
โ€”
P/E Ratio
โ€”
P/S Ratio
117.0x
EPS (TTM)
$-19.51
Dividend Yield
โ€”
GUTS logo

FRACTYL HEALTH INC

GUTS
Financial Trends

Financial history unavailable.

StockOtter ยท stockotter.space

About FRACTYL HEALTH INC

Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.

๐Ÿฆฆ

Otter Score Breakdown

How it's scoredFive components, each rated 1โ€“5โ˜… and equally weighted (20%), averaged to a 0โ€“100 score:๐Ÿ’Ž Quality โ€” gross margin๐Ÿš€ Growth โ€” revenue YoYโš–๏ธ Valuation โ€” P/S ratioโšก Momentum โ€” 30-day price change๐Ÿ’ง Dilution โ€” 1-yr share issuance (buybacks score higher)

Insufficient data for all five components.

๐Ÿ’ŽQualityโ˜…โ˜…โ˜…โ˜…โ˜…
โš–๏ธValuationโ˜…โ˜…โ˜…โ˜…โ˜…
Overall Score
Insufficient data
โ€”/100
Analyst data unavailable.

Latest News & Updates

News unavailable.